jueves, 10 de marzo de 2022

Engineered SARS-CoV-2 immunogens elicit broadly neutralizing antibodies

Engineered SARS-CoV-2 immunogens elicit broadly neutralizing antibodies

No hay comentarios:

Publicar un comentario